Skip to main content
Fig. 5 | BMC Bioinformatics

Fig. 5

From: Pan-cancer analysis of SYNGR2 with a focus on clinical implications and immune landscape in liver hepatocellular carcinoma

Fig. 5

Correlation between the expression of SYNGR2 with TMB, MSI, and immune scores in pan-cancer. A–B. Radar maps of correlations between SYNGR2 expression and TMB (A) or MSI (B). C. The scatter plots of correlation between SYNGR2 expression and immune scores in multiple cancers. *p < 0.05, **p < 0.01, and ***p < 0.001

Back to article page